Yushi Nagaki

Revision of lymph node classification in the Japanese Classification of Esophageal Cancer and its impact on definitive chemoradiotherapy for stage IV esophageal cancer: a single-institution retrospective study.

The 2022 revision of the Japanese Classification of Esophageal Cancer reclassified certain lymph node metastases previously considered locoregional as distant lymph node metastasis. Consequently, some patients previously diagnosed with stage IVA or III disease and treated with de...

P1.095. International Collaborative Study on the Relationship Between ALDH2 Gene Polymorphism and Changes in Salivary Acetaldehyde Concentration by L8020 Lactobacillus

Abstract Topic Esophageal Cancer: Esophageal Carcinogenesis Background Seventy-five percent of the world's esophageal cancer cases occur in Asia. The primary cause is the presence of the flasher (ALDH2 non-inactivating type). The ALDH2 gene polymorphism (rs671 G>A) is believed to...